Vitamin D in the human body comes from two sources: diet and exposure to ultraviolet B (UVB; 280–315 nm) radiation. The systemic effect of vitamin D produced by UVB action on the skin was demonstrated by the fact that UVB exposure of one arm of a child with rickets could cure rickets in the other arm(Reference Holick1). Vitamin D is formed by UVB action on 7-dehydrocholesterol (7-DHC) in skin, where the product previtamin D is transformed to vitamin D and transported to the liver bound to vitamin D-binding protein in the blood, as is dietary vitamin D. In the liver vitamin D is hydroxylated to 25-hydroxyvitamin D (25(OH)D), which is transported to the kidneys and to many other tissues and hydroxylated to 1,25-dihydroxyvitamin D (1,25(OH)2D), the active hormone, known for its classical role in bone ossification. A level of 25(OH)D in the blood of 20–30 nmol/l is needed to avoid rickets(Reference Holick2). Vitamin D gives many health benefits(Reference Holick2), beyond bone and muscle health, but they require higher blood levels(Reference Holick, Binkley and Bischoff-Ferrari3). Sun exposure produces vitamin D with high efficiency, making it the main source of vitamin D even at high latitudes. One minimal erythemal dose of UV radiation (a slight skin pinkness 24 h after exposure(Reference Holick, Binkley and Bischoff-Ferrari3)) gives about 250–625 μg of vitamin D(Reference Holick and Chen4).
Due to the fear of skin cancer(Reference Moan and Dahlback5–Reference Moan, Porojnicu and Dahlback7), health authorities warn against sun and sunbed exposure. This policy, as well as the recommended vitamin D doses, may need revision.
UV from sun and sunbeds
The sun and sunbeds emit UVB and ultraviolet A (UVA). Sunbed tubes with high fluence rates of UVA are allowed for two reasons: (i) UVA wavelengths are not significantly absorbed by DNA and do not affect DNA directly(Reference Von Thaler, Kamenisch and Berneburg8); and (ii) UVA produces skin tanning, both immediate pigment darkening (IPD) and delayed tanning. Tanning is thought to protect DNA and reduce carcinogenesis as indicated by the low skin cancer risk of dark-skinned people(Reference Marks9). The positive effects of UVB are not known, only its carcinogenetic potential. Thus, UVB levels are restricted to those in solar radiation which are sufficient to increase the vitamin D levels in the blood(Reference Cicarma, Porojnicu and Lagunova10–Reference Thieden, Jorgensen and Jorgensen13): 10 min of exposure to sunbeds, twice weekly, give similar vitamin D levels as a daily intake of 50 μg of vitamin D(Reference Moan, Lagunova and Cicarma11), or 5 teaspoons (25 ml) of cod-liver oil, and can bring a winter level of vitamin D up to a summer level (70–90 nmol/l), which may be optimal(Reference Holick, Binkley and Bischoff-Ferrari3).
Sun and cutaneous malignant melanoma
Sun exposure is commonly supposed to be the main cause of cutaneous malignant melanoma (CMM) in most populations(Reference Marks9). However, the matter is disputed(Reference Shuster14), and we have reviewed the arguments for and against a causation(Reference Moan, Porojnicu and Dahlback7). Several factors are probably involved, as exemplified by a relationship sometimes found between gross domestic product and CMM incidence(Reference Moan, Porojnicu and Dahlback6).
Intermittent sun exposure and severe sunburn in childhood are associated with an increased risk of CMM(Reference Leiter and Garbe15). CMM incidence rates per unit skin area are larger on trunk (intermittently exposed) than on head and neck, while the opposite is true for basal cell and squamous cell carcinomas(Reference Moan, Porojnicu and Dahlback7). Occupational exposure (farmers, fishermen) and regular weekend sun exposure are associated with decreased risk of CMM(Reference Newton-Bishop, Chang and Elliott16, Reference Pukkala, Martinsen and Lynge17). Sun exposure may even protect against CMM on shielded skin sites(Reference Cicarma, Juzeniene and Porojnicu18, Reference Moan, Cicarma and Setlow19), and CMM arising on skin with signs of large UV exposure has the best prognosis(Reference Berwick, Armstrong and Ben-Porat20). UV exposure earlier in life is related to reduced overall and breast cancer(Reference Yang, Veierod and Lof21). It has also been observed that patients with the highest blood levels of vitamin D have thinner CMM and better survival prognosis from CMM(Reference Newton-Bishop, Beswick and Randerson-Moor22).
Sunbeds and cutaneous malignant melanoma
A number of publications show conflicting results concerning the risk of CMM developing after sunbed use. Recent studies found that exposure to sunbeds has increased CMM risks(Reference Moan, Lagunova and Cicarma11, 23–Reference Walter, King and Marrett29). These studies show that the use of sunbeds before 35 years of age significantly increases CMM risk. Some other studies show no increased CMM risk associated with sunbed use(Reference Bataille, Boniol and De30–Reference Zanetti, Rosso and Faggiano34).
Discrepancies between different studies may be related to differences between UVA/UVB ratios and intensities of the sunbeds. People who are using sunbeds frequently may also have higher than average sun exposure and it may be difficult to separate the effects of the two factors. There has been a significant increase in the number of sunbed exposures in Norway after 1990, but CMM incidence rates among persons younger than 50 years have stabilized(Reference Moan, Porojnicu and Dahlback6, Reference Moan, Porojnicu and Dahlback7, Reference Moan, Baturaite and Porojnicu35, Reference Moan, Porojnicu and Dahlback36).
Figure 1 is an updated summary of the published studies on sunbed use and risk of CMM(23, Reference Cust, Armstrong and Goumas25, Reference Elliott, Suppa and Chan31, Reference Fears, Sagebiel and Halpern37–Reference Westerdahl, Ingvar and Masback40). Some of the studies give conflicting results, such as an increased risk for women but not for men(Reference Fears, Sagebiel and Halpern37). A recent study, including persons who were 18 years or younger between 1957 and 1977, gave among the highest odds ratios(Reference Veierod, Weiderpass and Thorn28, Reference Veierod, Adami and Lund39). However, in this period there were very few sunbeds in Norway, so sunbed exposure cannot be the only risk factor for the increasing rates of CMM.
Ultraviolet A and cutaneous malignant melanoma
UVA was reported to induce CMM with high efficiency in the small swordfish Xiphophorus (Reference Setlow, Grist and Thompson41). The opossum Monodelphis domestica also develops CMM-like lesions after UVA exposure, but with low potency compared with UVB(Reference Robinson, Hill and Kripke42). CMM are induced by UVB in a HGF/SF (hepatocyte growth factors/scatter factor) transgenic mouse model, but not by UVA(Reference Noonan, Dudek and Merlino43). Furthermore, it has recently been noted that UVA did not induce melanomas in Xiphophorus (Reference Mitchell, Fernandez and Nairn44), so the UVA involvement in CMM generation is not solved experimentally.
Epidemiological investigations suggest that the use of sunscreens that absorb only UVB, but transmit UVA, may contribute to the risk of CMM(Reference Gorham, Mohr and Garland45, Reference Nilsen, Aalerud and Hannevik46). Regular use of sunscreens absorbing both UVB and UVA perhaps reduces the CMM risk by approximately 50 %(Reference Green, Williams and Logan47).
All of these findings have not resulted in any reduction of the allowed UVA fluence rates in sunbeds, which still may emit five to ten times more UVA than noon summer sun in southern Europe(Reference Nilsen, Aalerud and Hannevik46). Most people get much more UVB and probably also more UVA from the sun than from sunbeds. This may not be true for frequent sunbed users.
The latitude gradient for CMM in Scandinavia, England, New Zealand and Australia is much lower than for non-melanomas(Reference Moan, Dahlback and Setlow48). Differences between Scandinavia and Australia are a factor of only two for CMM v. a factor of twenty to forty for non-melanomas(Reference Moan, Dahlback and Setlow48). The fact that the latitude gradient of ambient annual exposures is much smaller for UVA than for UVB (roughly a factor of 1·5 to 2·0 smaller) leads us to suggest that solar UVB is the main cause of non-melanomas and UVA may be CMM generating(Reference de Gruijl and Forbes49).
Sun and vitamin D
There is a seasonal variation of vitamin D status as the sun is its main source(Reference Moan, Porojnicu and Robsahm50). Latitude gradients for blood levels of vitamin D have been recorded in the UK(Reference Hypponen and Power51) and in France(Reference Chapuy, Preziosi and Maamer52), but international latitude gradients are not clearly documented. The reasons for this include varying methods of measuring vitamin D status(Reference Lai, Lucas and Banks53), varying skin types in different populations with less vitamin D produced in dark skin, and differences in intake of vitamin D-rich food in different countries. For example in Norway, people in the north eat more oily fish and consume more cod-liver oil than in the south(Reference Johansson and Solvoll54).
Young ethnic Norwegians and immigrants from southern countries in Norway have a low vitamin D status, notably in the winter(Reference Lagunova, Porojnicu and Lindberg55). This may be related to more indoor life. About 70 % of 15-year-old persons spend more than 4 h daily in front of a computer or television(56). They also spend more time on indoor activities and, therefore, less time out of doors during the day. Immigrants from South Asia usually cover their skin almost completely with clothes, and the women may cover their faces with veils. Compared with indigenous Norwegians they eat less vitamin D-containing oily fish and they have no tradition for cod-liver oil supplementation.
Benefits v. risks of UV exposure
Using the relationship between CMM risk and UV exposure and the results published by Giovanucci et al. (Reference Giovannucci, Liu and Rimm57), it can be estimated that increased sun exposure to the Norwegian population might at worst result in 200–300 more CMM deaths per year, but it would elevate the vitamin D status by about 25 nmol/l and might result in 4000 fewer internal cancers and about 3000 fewer cancer deaths overall(Reference Moan, Lagunova and Porojnicu58). The lack of sunlight exposure leads to more health problems than bone disease and increased risk for cancer(Reference Reichrath and Nurnberg59). Other benefits include protection against infectious diseases and non-cancerous diseases (diabetes, CVD, multiple sclerosis and mental disorders)(Reference Juzeniene, Brekke and Dahlback60). New trials assessing higher doses of vitamin D supplementation are in progress and future research may more clearly demonstrate the benefits of vitamin D(Reference Reichrath and Nurnberg59).
Acknowledgements
The present work was supported by the Norwegian Cancer Society (Kreftforeningen). The authors have no conflict of interest to declare. J.M., Z.B., A.J. and A.C.P. wrote the paper; J.M. and A.C.P. designed and implemented review and J.M. had primary responsibility for the final content. All authors read and approved the final manuscript.